Gutiérrez-Grobe Y, Vitek L, Tiribelli C, Kobashi-Margáin RA, Uribe M, Méndez-Sánchez N

Language: English
References: 16
Page: 105-107
PDF size: 34.81 Kb.

Text Extraction

Original Abstract:

Induction of heme oxygenase-1 (HO-1) inhibits hepatitis C virus (HCV) replication. Of the products of the reaction catalyzed by HO-1, iron has been shown to inhibit HCV ribonucleic acid (RNA) polymerase, but little is known about the antiviral activity of biliverdin (BV). Herein, we report that BV inhibits viral replication and viral protein expression in a dose-dependent manner in replicons and cells harboring the infectious J6/JFH construct.

REFERENCES

1. Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, Bandyopadhyay S, et al. Biliverdin Inhibits Hepatitis C Virus Nonstructural 3/4A Protease Activity: Mechanism for the Antiviral Effects of Heme Oxygenase? Hepatology 2010; 52: 1897-1905.

2. Zhu Z, Wilson AT, Mathans MM, Wen F, Brown KE, Luxon BA et al. Heme oxygenase-1 supresses hepatitis C rivus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008; 48: 1430-1439.

3. Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, et al. Hepatitis c virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol 2009; 50:872-882.

4. Vijayan V, Mueller S, Baumgart-Vogt E, Immenschuh S. Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol 2010; 16(25): 3112-3119.

5. Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28: 809-817.

6. Aztatzi-Santillán E, Nares-López FE, Márquez-Valadez B, Aguilera P, Chánez-Cárdenas ME.The Protective Role of Heme Oxygenase-1 in Cerebral Ischemia. Cent Nerv Syst Agents Med Chem 2010; 2010; 10(4): 310-6.

7. Öllinger R, Pratschke J.Role of heme oxygenase-1 in transplantation. Transpl Int. 2010; 23(11): 1071-81.

8. Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 2003; 38: 909-918.

9. Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007; 133: 1156- 1165.

10. McPhee F, Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS. Bile Pigmentes as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J. 1996; 320: 681-686.

11. Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1-57.

12. Qin XF. Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals. Gut 2007; 56: 1641-1642.

13. Ascenzi P, Fasano M. Heme-hemopexin: a “chronosteric” heme-protein. IUMB Life 2007; 59: 700-708.

14. Miller YI, Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Bioch Biophys Acta 1999; 1454: 153-164.

15. McDonagh AF. The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel? Free Radic Biol Med 2010; 49: 814-20.

16. Bonkovsky HL, Lambrecht RW, Naishadham DN. Genetic variations in heme oxygenase-1 and chronic hepatitis. Hepatology 2010; 52: 401-402.